Senior Principal Scientist
Genentech, Inc.
South San Francisco, California, United States
Nonclinical Program Considerations for Peptide Safety Assessment (S02)
Monday, November 18, 2024
9:00 AM - 12:00 PM CT
Regulatory and Nonclinical Safety Considerations for Intravitreal Peptide Development (S02-5)
Monday, November 18, 2024
11:15 AM - 11:45 AM CT